Xenous (XITO) a cash-less shell relying on shareholder advances as Malaysia deal looms

Xenous Holdings, Inc. (PINK: XITO) - Quarterly snapshot (period ended June 30, 2025)

Short take: Xenous is a non‑operating shell with no revenue, zero cash, and ongoing reliance on advances from its majority shareholder while it completes due diligence on a proposed Malaysia acquisition. Results show very small operating expenses and a modest quarterly loss, but balance sheet and liquidity metrics raise substantial going‑concern risk.

Key facts & statistics
- Reporting period: quarter ended June 30, 2025 (Form 10‑Q filed Aug 13, 2025).
- Shares outstanding: 760,250,000 common shares; weighted average shares for EPS: 760,250,000.
- Net loss (three months ended June 30, 2025): $(15,311) vs $(15,971) in prior year quarter.
- Operating expenses (Q): General & administrative $311; Professional fees $15,000; Total operating expenses $15,311.
- Basic & diluted loss per share: $(0.00).
- Accumulated deficit: $1,229,733 as of June 30, 2025 (up from $1,214,422 on Mar 31, 2025).
- Total liabilities: $918,933 as of June 30, 2025.
- Due to related party (Smartex Investment Ltd., majority shareholder holding 82%): $898,218 (June 30, 2025) vs $879,718 (Mar 31, 2025). Loan is non‑interest bearing and due on demand.
- Accounts payable and accrued liabilities: $20,715 (June 30, 2025).
- Capital deficiency: $(449,450); Total stockholders' deficit: $(918,933).
- Cash and cash equivalents: $0 at beginning and end of period; net cash used in operating activities $(18,500); net cash provided by financing (related party advances) $18,500.
- No revenue to date; company states it has had no business operations and is presently a shell.

What's happening inside the company
- The company has no active operations and depends on advances from Smartex Investment Ltd. to cover expenses.
- Management is conducting focused due diligence on a Malaysia‑based target involved in Aquilaria tree plantations and related products; preliminary due diligence was positive and final valuation/intangible asset review is expected to complete in H2 calendar 2025.
- Management says the acquisition would be the path to commence operations, but no definitive transaction has closed and timing/terms are uncertain.

Positive aspects (income statement / operations)
- Very low cash burn: quarterly operating loss is small at $15,311 and decreased slightly vs prior year quarter (-$660), driven mainly by lower professional/audit fees.
- Operating expense base is minimal (G&A $311), which limits near‑term funding needs if overhead remains low.
- Related party financing has covered operating cash needs (net operating cash use $(18,500) fully financed by $18,500 related party advances).

Negative aspects (income statement / financial health)
- No revenue generation - income statement shows zero sales and no operating activity since inception.
- Continued quarterly net losses add to an accumulated deficit of $1,229,733.
- Loss per share is small only because of very large share count; economics are not validated by operations.
- Zero cash on hand and negative working capital of $(918,933) create immediate liquidity risk; dependence on non‑interest bearing, demand loans from a related party is risky and not sustainable without outside financing or a completed acquisition.
- Professional fees remain the single largest recurring charge ($15,000 this quarter) despite no operations - indicative of ongoing administrative/audit costs required to remain SEC‑reporting.
- Independent auditors included a going concern explanatory paragraph; management's disclosure controls were reported not effective.

Risks, near‑term catalyst and conclusion
- Primary catalyst: completion of due diligence and closing of the announced Malaysia acquisition (expected final due diligence H2 2025). If completed, that could materially change operations and funding needs - but timing and terms are uncertain.
- Primary risks: no revenue, zero cash, material dependence on the majority shareholder for advances, stockholders' deficit, going‑concern uncertainty, and lack of effective disclosure controls.
- Bottom line: XITO is a shell with minimal quarterly expenses and an ongoing acquisition plan. Investors should treat it as a speculative turnaround/transaction play that currently lacks operating cash flow, generates operating losses, and carries significant financing and execution risk.